Artificial intelligence (AI) is changing the world. Corporations are racing to establish themselves as leaders in the field, ...

The Icahn School of Medicine at Mount Sinai has launched the AI Small Molecule Drug Discovery Center, a bold endeavor that harnesses artificial intelligence (AI) to revolutionize drug development.

Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ...

New center will use cutting-edge AI to accelerate the creation of life-saving medicines AI Small Molecule Drug Discovery ...

APL and Microsoft are partnering to advance robotics and materials discovery by leveraging artificial intelligence (AI).

The company aims to build an AI-powered discovery platform for defense attorneys, backed by venture capital firm UpWest, ...

Artificial intelligence (AI) is making significant strides in various fields, with drug discovery being one of the most impactful areas. The process of developing new drugs has traditionally been a ...

March 31 (Reuters) - Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ever external funding round led by Thrive Capital ...

With basic attorney training and achievable deployment, AI will reduce the risk of malpractice in 2025, not expand it.

Developing new drugs to treat illnesses has typically been a slow and expensive process. However, a team of researchers at ...

Isomorphic Labs raised $600 million in its first external funding round, led by Thrive Capital with participation from GV and ...

The funding is set to accelerate the development of Isomorphic’s AI drug design engine and advance clinical programmes.